A well-designed approach can benefit clinical trials from protocol design to site support.
Raja Shankar
Advertisement
Vice President, Machine Learning, Research and Development Solutions, IQVIA
Articles by Raja Shankar
Advertisement
Latest Updated Articles
Leveraging AI/Machine Learning as an End-to-End DifferentiatorPublished: December 12th 2024 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
